Benchmarking microfluidic and immunomagnetic platforms for isolating circulating tumor cells in pancreatic cancer

Key Points

• The inertial microfluidic platform significantly outperforms immunomagnetic separation for isolating circulating tumor cells.
• Label-free enrichment achieved through microfluidic technology can enhance early detection of pancreatic cancer.
• This research emphasizes the translational potential of microfluidic platforms for disease monitoring in clinical settings.
• The findings indicate improved efficiency in isolating rare cells, crucial for effective cancer monitoring and diagnosis.